Peptide-based immunotherapy for the treatment of atherosclerosis and the development of peptide-based assays for measuring the immune response to oxidized low density lipoprotein
The present invention relates to antibodies raised against fragments of apolipoprotein B, in particular defined peptides thereof, for immunization or therapeutic treatment of mammals, including humans, against ischemic cardiovascular diseases, using one or more of said antibodies.